BMY Nov 2024 52.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:51PM EDT. Market open.
| Previous close | 3.0600 |
| Open | 3.0500 |
| Bid | 3.1000 |
| Ask | 3.2500 |
| Strike | 52.50 |
| Expiry date | 2024-11-15 |
| Day's range | 2.9200 - 3.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 8.39k |
ZacksBristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors
The latest trading day saw Bristol Myers Squibb (BMY) settling at $54.20, representing a +0.82% change from its previous close.
Business WireU.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)
PRINCETON, N.J., October 03, 2024--U.S. FDA Approves Perioperative Treatment of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo...
Investor's Business DailyBristol-Myers Squibb's Profits, Stock Price Kick Into High Gear
A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue?
© 2024 Yahoo. All rights reserved.